Comparison

SARS-CoV-2 Pseudoviral Particles (South Africa Variant, beta, B.1.351)

Item no. EEZ-SCV2-PsV-SA
Manufacturer eEnzyme
Amount 5 ml
Category
Type Molecules
Specific against other
Dry ice Yes
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Shipping Condition Dry ice
Available
Manufacturer - Applications
Our Pseudovirus Particles generate robust chemiluminescent signals in cell assays when coupled with our firefly luciferase assay kit (Catalog # CA-L165), useful for 1) screening potential inhibitors to block SARS-CoV-2 entry and viral protein; 2) measuring the activity of and screening for neutralizing antibody against SARS-CoV-2. 
Manufacturer - Category
3) Pseudovirus and Related Cell Lines etc. / 3.1) SARS-CoV-2 Pseudoviral Particles (aka. Pseudovirus) and Related Cell Lines etc.
Shipping Temperature
With dry ice
Storage Conditions
 -70oC. Shipped on dry ice.
Description
The SARS-CoV-2 Pseudoviral Particles are replication-deficient Maloneymurine leukemia virus (MLV or MuLV) pseudotyped with the SARS-CoV-2 spike protein of the Beta Variant (South Africa B.1.351, a.k.a. 20H/501Y.V2, formerly 20C/501Y.V2) (GISAID sequence accession number: EPI_ISL_736980). MLV-based virus system is a better choice than HIV-based lentivirus system for making pseudoviral particles in regards of lab safety and product quality. Gag-Pol is the only component from MLV.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 ml
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close